Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Neil Stahl. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Se högst rankade insiders
Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Neil Stahl har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
US:REGN / Regeneron Pharmaceuticals, Inc. EVP Research and Development 48 829
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Neil Stahl. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Neil Stahl som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris		 Transaktionsvärde Återstående
värde
2024-12-18 2024-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −304 48 829 −0,62 730,81 −222 166 35 684 721
2024-12-10 2024-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −466 49 133 −0,94 787,00 −366 742 38 667 671
2024-08-14 2024-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −500 49 599 −1,00
2024-08-12 2024-08-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −900 50 099 −1,76
2024-08-12 2024-08-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −300 50 999 −0,58 1 086,15 −325 845 55 392 564
2024-08-12 2024-08-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 708 51 299 −3,22 1 085,01 −1 853 197 55 659 928
2024-08-12 2024-08-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 883 53 007 −3,43 1 084,61 −2 042 321 57 491 922
2024-08-12 2024-08-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 006 54 890 −1,80 1 083,76 −1 090 263 59 487 586
2024-08-12 2024-08-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −200 55 896 −0,36 1 082,69 −216 538 60 518 040
2024-08-12 2024-08-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 56 096 −0,18 1 081,83 −108 183 60 686 336
2024-08-06 2024-08-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −18 441 56 196 −24,71 1 093,49 −20 165 049 61 449 764
2024-08-06 2024-08-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23 638 74 637 46,35 555,67 13 134 927 41 473 542
2024-02-28 2024-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −1 020 50 999 −1,96
2024-02-08 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −19 52 019 −0,04 953,00 −18 107 49 574 107
2024-02-08 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 059 52 038 −1,99 952,49 −1 008 687 49 565 675
2024-02-08 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 237 53 097 −2,28 951,49 −1 176 993 50 521 265
2024-02-08 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 127 54 334 −5,44 950,43 −2 971 995 51 640 664
2024-02-08 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −601 57 461 −1,04 949,45 −570 619 54 556 346
2024-02-08 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 894 58 062 −3,16 948,69 −1 796 819 55 082 839
2024-02-08 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 59 956 −0,17 947,34 −94 734 56 798 717
2024-02-06 2024-02-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −22 713 60 056 −27,44 956,65 −21 728 391 57 452 572
2024-02-06 2024-02-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 30 750 82 769 59,11 399,66 12 289 545 33 079 459
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −725 52 019 −1,37 844,09 −611 965 43 908 718
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 853 52 744 1,64
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −809 51 891 −1,54 843,79 −682 626 43 785 107
2023-11-14 2023-11-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −400 52 700 −0,75
2023-08-23 2023-08-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −782 53 100 −1,45 842,16 −658 569 44 718 696
2023-08-23 2023-08-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −4 574 53 882 −7,82 841,41 −3 848 609 45 336 854
2023-08-23 2023-08-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −6 309 58 456 −9,74 840,53 −5 302 904 49 134 022
2023-08-23 2023-08-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −38 335 64 765 −37,18 833,39 −31 948 006 53 974 503
2023-08-23 2023-08-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 50 000 103 100 94,16 399,66 19 983 000 41 204 946
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 1 101 53 100 2,12
2022-12-13 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −466 51 999 −0,89 753,28 −351 028 39 169 807
2022-12-13 2022-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −330 52 465 −0,63
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 52 795 −0,19 621,11 −62 111 32 791 502
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −177 52 895 −0,33 620,11 −109 759 32 800 718
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −502 53 072 −0,94 619,64 −311 059 32 885 534
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −521 53 574 −0,96 618,27 −322 119 33 123 197
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −424 54 095 −0,78 617,43 −261 790 33 399 876
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −535 54 519 −0,97 616,40 −329 774 33 605 512
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 610 55 054 −2,84 615,49 −990 939 33 885 186
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −4 112 56 664 −6,77 614,35 −2 526 207 34 811 528
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 218 60 776 −5,03 613,49 −1 974 211 37 285 468
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 076 63 994 −3,14 612,43 −1 271 405 39 191 845
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 022 66 070 −2,97 611,44 −1 236 332 40 397 841
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 931 68 092 −5,46 610,49 −2 399 836 41 569 485
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 044 72 023 −4,06 609,62 −1 855 683 43 906 661
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −610 75 067 −0,81 608,70 −371 307 45 693 283
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −724 75 677 −0,95 607,47 −439 808 45 971 507
2022-08-08 2022-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −176 76 401 −0,23 606,78 −106 793 46 358 599
2022-08-08 2022-08-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −71 218 76 577 −48,19 613,00 −43 656 634 46 941 701
2022-08-08 2022-08-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 95 000 147 795 179,94 270,43 25 690 850 39 968 202
2022-08-08 2022-02-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −335 52 795 −0,63
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −753 53 130 −1,40 664,34 −500 248 35 296 384
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 12 494 12 494
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 2 926 53 883 5,74
2021-12-06 2021-12-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −72 500 0 −100,00
2021-12-06 2021-12-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −50 352 50 957 −49,70 632,45 −31 845 122 32 227 755
2021-12-06 2021-12-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 72 500 101 309 251,66 179,13 12 986 925 18 147 481
2021-12-06 2021-11-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 4 605 4 605
2021-12-06 2021-11-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −4 605 28 809 −13,78
2021-05-18 2021-05-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 806 24 280 −13,55 520,17 −1 979 767 12 629 728
2021-05-18 2021-05-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −10 336 28 086 −26,90 519,47 −5 369 242 14 589 834
2021-05-18 2021-05-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 379 38 422 −8,08 518,63 −1 752 451 19 926 802
2021-05-18 2021-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −40 000 72 500 −35,56
2021-05-18 2021-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −12 500 0 −100,00
2021-05-18 2021-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −7 204 41 801 −14,70 516,69 −3 722 235 21 598 159
2021-05-18 2021-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 12 500 49 005 34,24 52,03 650 375 2 549 730
2021-05-18 2021-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −27 775 36 505 −43,21 516,69 −14 351 065 18 861 768
2021-05-18 2021-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 40 000 64 280 164,74 179,13 7 165 200 11 514 476
2021-05-18 2021-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −435 24 280 −1,76
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 17 500 17 500
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 1 688 24 715 7,33
2020-12-11 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −750 20 979 −3,45
2020-05-11 2020-05-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 026 11 380 −15,11 570,28 −1 155 387 6 489 786
2020-05-11 2020-05-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 175 13 406 −13,96 569,39 −1 238 423 7 633 242
2020-05-11 2020-05-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −792 15 581 −4,84 568,71 −450 418 8 861 071
2020-05-11 2020-05-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −312 16 373 −1,87 567,50 −177 060 9 291 678
2020-05-11 2020-05-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −12 500 12 500 −50,00
2020-05-11 2020-05-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −7 195 16 685 −30,13 560,67 −4 034 021 9 354 779
2020-05-11 2020-05-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 12 500 23 880 109,84 52,03 650 375 1 242 476
2020-04-15 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −357 11 380 −3,04 524,26 −187 161 5 966 079
2020-04-15 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −758 11 737 −6,07 522,37 −395 956 6 131 057
2020-04-15 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 595 12 495 −11,32 521,32 −831 505 6 513 893
2020-04-15 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 096 14 090 −12,95 520,43 −1 090 821 7 332 859
2020-04-15 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −422 16 186 −2,54 519,85 −219 377 8 414 292
2020-04-15 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −267 16 608 −1,58 518,54 −138 450 8 611 912
2020-04-15 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 16 875 −0,01 517,99 −1 036 8 741 081
2020-04-15 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −13 079 25 000 −34,35
2020-04-15 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −7 582 16 877 −31,00 511,56 −3 878 648 8 633 598
2020-04-15 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 13 079 24 459 114,93 52,03 680 500 1 272 602
2020-02-28 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −25 000 38 079 −39,63
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −31 11 380 −0,27 468,56 −14 525 5 332 213
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −227 11 411 −1,95 465,42 −105 650 5 310 908
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −126 11 638 −1,07 464,14 −58 482 5 401 661
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −123 11 764 −1,03 463,10 −56 961 5 447 908
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 11 887 −0,01 462,15 −462 5 493 577
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −614 11 888 −4,91 461,24 −283 201 5 483 221
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −252 12 502 −1,98 460,34 −116 006 5 755 171
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −692 12 754 −5,15 459,47 −317 953 5 860 080
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −460 13 446 −3,31 458,59 −210 951 6 166 201
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −141 13 906 −1,00 457,27 −64 475 6 358 797
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −743 14 047 −5,02 456,63 −339 276 6 414 282
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 967 14 790 −16,71 455,56 −1 351 647 6 737 732
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −102 17 757 −0,57 454,58 −46 367 8 071 977
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −113 17 859 −0,63 453,45 −51 240 8 098 164
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −130 17 972 −0,72 452,08 −58 770 8 124 782
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −233 18 102 −1,27 451,47 −105 193 8 172 510
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −125 18 335 −0,68 450,10 −56 262 8 252 584
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −236 18 460 −1,26 449,53 −106 089 8 298 324
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −240 18 696 −1,27 448,86 −107 726 8 391 887
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −120 18 936 −0,63 445,91 −53 509 8 443 752
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −490 19 056 −2,51 444,65 −217 878 8 473 250
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −264 19 546 −1,33 443,67 −117 129 8 671 974
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −395 19 810 −1,95 440,24 −173 895 8 721 154
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −231 20 205 −1,13 439,73 −101 578 8 884 745
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −256 20 436 −1,24 438,63 −112 289 8 963 843
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −480 20 692 −2,27 437,41 −209 957 9 050 888
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −348 21 172 −1,62 436,43 −151 878 9 240 096
2020-02-28 2020-02-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −209 21 520 −0,96 435,93 −91 109 9 381 214
2020-02-28 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −14 651 21 729 −40,27 451,89 −6 620 640 9 819 118
2020-02-28 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 25 000 36 380 219,68 52,03 1 300 750 1 892 851
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −31 11 380 −0,27 406,44 −12 600 4 625 287
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 279 11 411 −10,08 402,35 −514 606 4 591 216
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 058 12 690 −13,95 401,46 −826 205 5 094 527
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 608 14 748 −15,03 400,54 −1 044 608 5 907 164
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 302 17 356 −19,86 399,80 −1 719 940 6 938 929
2020-02-14 2020-02-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −25 000 63 079 −28,38
2020-02-14 2020-02-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −14 722 21 658 −40,47 402,34 −5 923 249 8 713 880
2020-02-14 2020-02-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 25 000 36 380 219,68 52,03 1 300 750 1 892 851
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 24 500 24 500
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 2 625 11 380 29,98
2019-11-26 2019-11-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −300 22 455 −1,32 365,41 −109 623 8 205 282
2019-11-26 2019-11-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 284 22 755 −9,12 364,20 −831 833 8 287 371
2019-11-26 2019-11-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 422 25 039 −5,37 363,58 −517 011 9 103 680
2019-11-26 2019-11-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −10 000 88 079 −10,20
2019-11-26 2019-11-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −5 994 26 461 −18,47 362,75 −2 174 324 9 598 728
2019-11-26 2019-11-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10 000 32 455 44,53 52,03 520 300 1 688 634
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −300 22 455 −1,32 341,38 −102 414 7 665 688
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 064 22 755 −8,32 340,48 −702 751 7 747 622
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 100 24 819 −4,24 339,53 −373 483 8 426 795
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 100 25 919 −4,07 338,54 −372 394 8 774 618
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 500 27 019 −5,26 337,41 −506 115 9 116 481
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −500 28 519 −1,72 336,73 −168 365 9 603 203
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −400 29 019 −1,36 335,45 −134 180 9 734 424
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 29 419 −0,34 334,66 −33 466 9 845 363
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −200 29 519 −0,67 333,32 −66 664 9 839 273
2019-11-12 2019-11-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 29 719 −0,34 330,56 −33 056 9 823 913
2019-11-12 2019-05-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −1 300 21 150 −5,79
2019-05-15 2019-05-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 278 22 450 −12,74 306,37 −1 004 281 6 878 006
2019-05-15 2019-05-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −6 575 25 728 −20,35 305,43 −2 008 202 7 858 103
2019-05-15 2019-05-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −25 000 98 079 −20,31
2019-05-15 2019-05-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −15 147 32 303 −31,92 304,20 −4 607 717 9 826 573
2019-05-15 2019-05-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 25 000 47 450 111,36 52,03 1 300 750 2 468 824
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 20 000 20 000
2018-05-25 2018-05-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −11 407 31 973 −26,30 295,09 −3 366 092 9 434 913
2018-05-25 2018-05-23 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −26 736 0 −100,00
2018-05-25 2018-05-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −15 329 43 380 −26,11 293,68 −4 501 821 12 739 838
2018-05-25 2018-05-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 26 736 58 709 83,62 30,63 818 924 1 798 257
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 50 000 50 000
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 23 950 −0,42 541,70 −54 170 12 973 715
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 24 050 −0,41 540,04 −54 004 12 987 962
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −200 24 150 −0,82 539,36 −107 872 13 025 544
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −600 24 350 −2,40 538,39 −323 034 13 109 796
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −200 24 950 −0,80 537,42 −107 484 13 408 629
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −800 25 150 −3,08 536,46 −429 168 13 491 969
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −800 25 950 −2,99 535,37 −428 296 13 892 852
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −700 26 750 −2,55 534,64 −374 248 14 301 620
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −905 27 450 −3,19 533,49 −482 808 14 644 300
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −500 28 355 −1,73 532,44 −266 220 15 097 336
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −900 28 855 −3,02 531,42 −478 278 15 334 124
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −800 29 755 −2,62 530,64 −424 512 15 789 193
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 30 555 −0,33 529,61 −52 961 16 182 234
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −600 30 655 −1,92 526,45 −315 870 16 138 325
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −400 31 255 −1,26 525,10 −210 040 16 412 000
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −101 31 655 −0,32 524,08 −52 932 16 589 752
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −200 31 756 −0,63 523,52 −104 704 16 624 901
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −200 31 956 −0,62 522,80 −104 560 16 706 597
2017-06-23 2017-06-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 32 156 −0,31 521,70 −52 170 16 775 785
2017-06-23 2017-06-21 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −20 000 26 736 −42,79
2017-06-23 2017-06-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −10 493 32 256 −24,55 510,02 −5 351 640 16 451 205
2017-06-23 2017-06-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 201 42 749 −2,73 510,02 −612 534 21 802 845
2017-06-23 2017-06-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 20 000 43 950 83,51 30,63 612 600 1 346 188
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 23 950 −0,42 474,48 −47 448 11 363 796
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 24 050 −0,41 472,95 −47 295 11 374 448
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 24 150 −0,41 471,15 −47 115 11 378 272
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 426 24 250 −9,09 470,57 −1 141 603 11 411 322
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 212 26 676 −7,66 469,53 −1 038 600 12 525 182
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −900 28 888 −3,02 468,63 −421 767 13 537 783
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −300 29 788 −1,00 467,82 −140 346 13 935 422
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −185 30 088 −0,61 466,52 −86 306 14 036 654
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 244 30 273 −3,95 465,49 −579 070 14 091 779
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −400 31 517 −1,25 464,69 −185 876 14 645 635
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 31 917 −0,31 463,91 −46 391 14 806 615
2017-06-16 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −500 32 017 −1,54 462,72 −231 360 14 814 906
2017-06-16 2017-06-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −20 295 0 −100,00
2017-06-16 2017-06-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −10 822 32 517 −24,97 475,56 −5 146 510 15 463 785
2017-06-16 2017-06-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −906 43 339 −2,05 475,56 −430 857 20 610 295
2017-06-16 2017-06-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 20 295 44 245 84,74 21,25 431 269 940 206
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −200 23 950 −0,83 483,42 −96 684 11 577 909
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −808 24 150 −3,24 482,56 −389 908 11 653 824
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −695 24 958 −2,71 481,64 −334 740 12 020 771
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −309 25 653 −1,19 480,71 −148 539 12 331 654
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 25 962 −0,38 479,00 −47 900 12 435 798
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 26 062 −0,38 476,52 −47 652 12 419 064
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 26 162 −0,38 475,33 −47 533 12 435 583
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 26 262 −0,38 474,82 −47 482 12 469 723
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 26 362 −0,38 472,10 −47 210 12 445 500
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 26 462 −0,38 470,49 −47 049 12 450 106
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 26 562 −0,38 469,83 −46 983 12 479 624
2017-06-05 2017-06-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 26 662 −0,37 466,33 −46 633 12 433 290
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −4 527 0 −100,00
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −6 017 0 −100,00
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −2 167 26 762 −7,49 464,98 −1 007 612 12 443 795
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 885 28 929 −6,12 464,98 −876 487 13 451 406
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 6 017 30 814 24,27 145,70 876 677 4 489 600
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 068 24 797 −4,13 464,98 −496 599 11 530 109
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −2 612 25 865 −9,17 464,98 −1 214 528 12 026 708
2017-06-05 2017-06-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 4 527 28 477 18,90 268,40 1 215 047 7 643 227
2016-12-20 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 58 342 58 342
2016-12-20 2016-11-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −7 876 23 950 −24,75
2016-12-20 2016-02-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −1 500 40 470 −3,57
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 68 638 68 638
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −1 921 0 −100,00
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 1 921 27 594 7,48 52,03 99 950 1 435 716
2015-11-09 2015-11-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −900 22 029 −3,93 563,41 −507 069 12 411 359
2015-11-09 2015-11-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −5 607 22 929 −19,65 562,31 −3 152 872 12 893 206
2015-11-09 2015-11-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −500 28 536 −1,72 561,36 −280 680 16 018 969
2015-11-09 2015-11-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 900 29 036 −11,84 560,31 −2 185 209 16 269 161
2015-11-09 2015-11-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 500 32 936 −4,36 559,26 −838 890 18 419 787
2015-11-09 2015-11-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −9 694 34 436 −21,97 558,37 −5 412 839 19 228 029
2015-11-09 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 100 44 130 −4,54 564,19 −1 184 799 24 897 705
2015-11-09 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −8 345 46 230 −15,29 563,43 −4 701 823 26 047 369
2015-11-09 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −9 555 54 575 −14,90 562,37 −5 373 445 30 691 343
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −75 000 46 736 −61,61
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −25 000 20 295 −55,19
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −13 312 64 130 −17,19 567,63 −7 556 291 36 402 112
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −935 77 442 −1,19 567,63 −530 734 43 958 402
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 25 000 78 377 46,84 21,25 531 250 1 665 511
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −39 605 53 377 −42,59 567,63 −22 480 986 30 298 387
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 047 92 982 −4,17 567,63 −2 297 199 52 779 373
2015-11-09 2015-11-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 75 000 97 029 340,46 30,63 2 297 250 2 971 998
2015-11-09 2015-05-28 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −1 000 16 405 −5,75
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 80 750 80 750
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 75 000 123 079 155,99
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −3 264 0 −100,00
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 3 264 6 541 99,60 30,63 99 976 200 351
2014-11-24 2014-11-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −413 3 277 −11,19 410,10 −169 371 1 343 898
2014-11-24 2014-11-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 787 3 690 −32,63 409,71 −732 152 1 511 830
2014-11-24 2014-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 107 5 477 −36,20 415,16 −1 289 902 2 273 831
2014-11-20 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −16 757 0 −100,00
2014-11-20 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −250 18 584 −1,33
2014-11-20 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −6 703 18 834 −26,25 406,93 −2 727 652 7 664 120
2014-11-20 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 747 25 537 −15,67 406,93 −1 931 697 10 391 771
2014-11-20 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 16 757 30 284 123,88 115,29 1 931 915 3 491 442
2014-08-11 2014-08-11 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −200 13 527 −1,46 341,27 −68 254 4 616 359
2014-08-11 2014-08-11 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −9 829 13 727 −41,73 340,04 −3 342 253 4 667 729
2014-08-11 2014-08-11 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 617 23 556 −6,42 339,33 −548 697 7 993 257
2014-08-08 2014-08-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −200 25 173 −0,79 341,00 −68 200 8 583 993
2014-08-08 2014-08-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 900 25 373 −6,97 340,60 −647 140 8 642 044
2014-08-08 2014-08-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −117 27 273 −0,43 341,03 −39 901 9 300 911
2014-08-08 2014-08-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −624 27 390 −2,23 340,39 −212 403 9 323 282
2014-08-08 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −35 000 45 295 −43,59
2014-08-08 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −18 301 28 014 −39,51 336,11 −6 151 149 9 415 786
2014-08-08 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −2 212 46 315 −4,56 336,11 −743 475 15 566 935
2014-08-08 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 35 000 48 527 258,74 21,25 743 750 1 031 199
2014-02-13 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 640 24 391 −6,30 321,17 −526 719 7 833 657
2014-02-13 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 575 26 031 −12,08 320,60 −1 146 145 8 345 539
2014-02-13 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 819 29 606 −11,43 319,47 −1 220 056 9 458 229
2014-02-13 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −6 418 33 425 −16,11 318,51 −2 044 197 10 646 197
2014-02-13 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −5 360 39 843 −11,86 317,58 −1 702 229 12 653 340
2014-02-13 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 800 45 203 −3,83 316,55 −569 790 14 309 010
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −40 000 80 295 −33,25
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −6 548 0 −100,00
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −8 000 6 548 −54,99
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −3 465 47 003 −6,87 324,44 −1 124 185 15 249 653
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −339 50 468 −0,67 324,44 −109 985 16 373 838
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 6 548 50 807 14,79 16,80 110 006 853 558
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 234 44 259 −8,73 324,44 −1 373 679 14 359 390
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −414 48 493 −0,85 324,44 −134 318 15 733 069
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 8 000 48 907 19,56 16,80 134 400 821 638
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −20 865 40 907 −33,78 324,44 −6 769 441 13 271 867
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −2 619 61 772 −4,07 324,44 −849 708 20 041 308
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 40 000 64 391 163,99 21,25 850 000 1 368 309
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 705 0 −100,00
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 705 24 391 23,90 21,25 99 981 518 309
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −9 302 19 686 −32,09 272,73 −2 536 934 5 368 963
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 95 000 95 000
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 75 000 121 736 160,48
2013-05-14 2013-05-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −9 660 48 988 −16,47 277,12 −2 676 979 13 575 555
2013-05-14 2013-05-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −13 378 58 648 −18,57 276,71 −3 701 826 16 228 488
2013-05-14 2013-05-10 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 4 527 4 527
2013-05-14 2013-05-10 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −55 438 0 −100,00
2013-05-14 2013-05-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −27 873 72 026 −27,90 268,40 −7 481 113 19 331 778
2013-05-14 2013-05-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 527 99 899 −4,34 268,40 −1 215 047 26 812 892
2013-05-14 2013-05-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 55 438 104 426 113,17 21,92 1 215 201 2 289 018
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −5 952 0 −100,00
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 5 952 48 988 13,83 16,80 99 994 822 998
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 112 500 112 500
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 75 000 120 295 165,58
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −8 386 43 036 −16,31 179,13 −1 502 184 7 709 039
2012-12-03 2012-11-30 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 562 0 −100,00
2012-12-03 2012-11-30 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 921 0 −100,00
2012-12-03 2012-11-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 921 51 422 10,58 20,32 99 995 1 044 895
2012-12-03 2012-11-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 562 46 501 10,88 21,92 99 999 1 019 302
2012-12-03 2012-11-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −17 182 41 939 −29,06 181,01 −3 110 114 7 591 378
2012-11-21 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 000 59 121 −3,27 175,49 −350 980 10 375 144
2012-11-21 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −13 157 61 121 −17,71 174,47 −2 295 502 10 663 781
2012-11-21 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −9 200 74 278 −11,02 173,80 −1 598 960 12 909 516
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −37 500 14 548 −72,05
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −17 000 52 048 −24,62
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −16 973 83 478 −16,90 167,17 −2 837 376 13 955 017
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −3 768 100 451 −3,62 167,17 −629 897 16 792 394
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 37 500 104 219 56,21 16,80 630 000 1 750 879
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −7 694 66 719 −10,34 167,17 −1 286 206 11 153 415
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −1 708 74 413 −2,24 167,17 −285 526 12 439 621
2012-11-21 2012-11-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 17 000 76 121 28,75 16,80 285 600 1 278 833
2012-08-30 2012-08-29 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −5 998 59 121 −9,21 146,41 −878 167 8 655 906
2012-08-30 2012-08-29 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −9 386 65 119 −12,60 145,44 −1 365 100 9 470 907
2012-08-30 2012-08-29 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 500 74 505 −1,97 144,92 −217 380 10 797 265
2012-08-30 2012-08-28 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 6 017 6 017
2012-08-30 2012-08-28 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −40 000 55 438 −41,91
2012-08-30 2012-08-28 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −17 099 76 005 −18,37 145,70 −2 491 324 11 073 928
2012-08-30 2012-08-28 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −6 017 93 104 −6,07 145,70 −876 677 13 565 253
2012-08-30 2012-08-28 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 40 000 99 121 67,66 21,92 876 800 2 172 732
2012-06-20 2012-06-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −600 59 121 −1,00 118,10 −70 860 6 982 190
2012-06-20 2012-06-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −4 383 59 721 −6,84 117,34 −514 301 7 007 662
2012-06-20 2012-06-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −9 080 64 104 −12,41 116,41 −1 057 003 7 462 347
2012-06-20 2012-06-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −24 848 73 184 −25,35 115,60 −2 872 429 8 460 070
2012-06-20 2012-06-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award X 16 757 16 757
2012-06-20 2012-06-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −95 079 0 −100,00
2012-06-20 2012-06-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −39 411 98 032 −28,67 115,29 −4 543 694 11 302 109
2012-06-20 2012-06-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −16 757 137 443 −10,87 115,29 −1 931 915 15 845 803
2012-06-20 2012-06-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 95 079 154 200 160,82 20,32 1 932 005 3 133 344
2012-02-15 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 025 59 121 −3,31 108,09 −218 882 6 390 389
2012-02-15 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −19 057 61 146 −23,76 107,79 −2 054 154 6 590 927
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −50 000 69 048 −42,00
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −600 80 203 −0,74 113,47 −68 082 9 100 634
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 115 80 803 −1,36 112,10 −124 992 9 058 016
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −600 81 918 −0,73 111,91 −67 146 9 167 443
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −17 694 82 518 −17,66 110,35 −1 952 533 9 105 861
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −8 510 100 212 −7,83 109,61 −932 781 10 984 237
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 350 108 722 −2,12 108,60 −255 210 11 807 209
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −333 111 072 −0,30 107,83 −35 907 11 976 894
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −21 352 111 405 −16,08 111,01 −2 370 286 12 367 069
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −7 566 132 757 −5,39 111,01 −839 902 14 737 355
2012-02-15 2012-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 50 000 140 323 55,36 16,80 840 000 2 357 426
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −3 432 0 −100,00
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −63 234 3 432 −94,85
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −1 597 90 323 −1,74 113,35 −181 020 10 238 112
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −257 91 920 −0,28 113,35 −29 131 10 419 132
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 3 432 92 177 3,87 8,50 29 172 783 504
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −28 869 88 745 −24,55 113,35 −3 272 301 10 059 246
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 741 117 614 −3,87 113,35 −537 392 13 331 547
2012-02-15 2012-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 63 234 122 355 106,96 8,50 537 489 1 040 018
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −780 4 297 −15,36 25,75 −20 085 110 648
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 083 5 077 −29,09 25,65 −53 429 130 225
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −694 7 160 −8,84 25,62 −17 780 183 439
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −70 7 854 −0,88 25,61 −1 793 201 141
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −5 972 7 924 −42,98 25,60 −152 883 202 854
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −70 13 896 −0,50 25,57 −1 790 355 321
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −139 13 966 −0,99 25,56 −3 553 356 971
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −486 14 105 −3,33 25,55 −12 417 360 383
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −152 14 591 −1,03 25,50 −3 876 372 070
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 14 743 −0,01 25,49 −25 375 799
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −208 14 744 −1,39 25,45 −5 294 375 235
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −69 14 952 −0,46 25,44 −1 755 380 379
2007-04-24 2007-04-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −264 15 021 −1,73 25,41 −6 708 381 684
2007-04-24 2007-04-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −25 000 25 000 −50,00
2007-04-24 2007-04-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −5 609 15 285 −26,85 26,09 −146 339 398 786
2007-04-24 2007-04-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −8 403 20 894 −28,68 26,09 −219 234 545 124
2007-04-24 2007-04-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 25 000 29 297 581,80 8,77 219 250 256 935
2004-04-23 2003-01-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −250 15 482 −1,59 19,65 −4 912 304 221
2003-12-17 2003-12-15 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 92 308 92 308
2003-12-17 2003-12-15 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		A - Award 7 692 7 692
2003-12-17 2003-12-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		A - Award 6 977 17 441 66,68
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)